Bio-Rad Laboratories Inc
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 1996 | 1997 | 1998 | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -36.4% | +29.4% | +64.8% | -46.1% | +310.3% | +6.3% | +20.7% | -3.6% | -12.0% | +9.2% | +62.0% | -0.1% | +69.9% | -30.5% | +16.3% | +1.4% | -36.5% | +61.6% | -31.9% | +16.0% | -51.8% | +174.2% | +60.4% | +27.8% | +14.4% | -71.0% | +92.8% | +21.4% | +16.9% | |
| – | +8.9% | +7.6% | +31.1% | +57.5% | -4.6% | -8.0% | +10.5% | +32.1% | +9.9% | -9.2% | +21.5% | +44.3% | +4.7% | +7.1% | +11.1% | +7.8% | +12.9% | +1.8% | -12.1% | +8.4% | +4.1% | -7.1% | -2.8% | +3.3% | -0.7% | -0.2% | +6.3% | +3.9% | +9.1% | |
| – | – | – | – | – | – | – | – | – | -102.4% | – | -9.3% | +49.0% | +24.7% | +12.1% | +4.9% | +23.4% | +3.8% | +8.8% | +14.1% | +15.9% | +18.8% | +18.8% | +28.1% | +16.9% | +23.1% | +18.9% | +0.7% | +1.6% | -6.9% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -57.2% | -900.3% | – | – | – | – | – | – | – | |
| – | – | – | – | -284.4% | – | – | -152.6% | – | – | – | – | -548.6% | – | -243.2% | – | – | – | – | -474.0% | – | – | – | +621.9% | +95.9% | +5.0% | -240.8% | – | – | – | |
| – | +260.5% | -61.3% | +985.4% | -86.4% | +37.6% | -2.3% | +63.4% | -12.3% | -40.4% | +47.0% | +18.3% | +41.7% | -14.0% | +21.2% | +11.7% | +40.0% | -25.8% | +27.1% | -16.9% | +24.9% | -18.7% | +12.8% | -24.1% | +10.2% | +23.2% | -14.6% | +37.2% | +20.6% | -16.6% | |
| – | +277.7% | -54.7% | +782.6% | – | -611.4% | +14.6% | +249.3% | -2.1% | -96.7% | +3,266.0% | +22.5% | -42.6% | +20.4% | +23.1% | +78.4% | +3.6% | – | -20,830.3% | -12.4% | +28.2% | -17.9% | +6.5% | +11.7% | -66.5% | +1,040.8% | +51.4% | – | -892.8% | +18.4% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -99.5% | +174,580.7% | +93.3% | +46.8% | – | – | |
| – | +178.9% | -11.3% | -53.2% | -82.8% | -31.0% | – | – | – | – | – | – | – | – | – | – | – | – | +33.9% | -45.3% | +37.0% | -125.9% | +1,575.1% | -42.8% | +257.2% | -50.0% | +331.4% | +98.8% | -52.5% | +45.1% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | +48,316.1% | -99.2% | -87.9% | -5.7% | +32.3% | +741.2% | -78.3% | +66,297.8% | -99.3% | – | -100.0% | -20.0% | +25.0% | |
| – | – | -102.7% | – | -122.8% | -51.5% | +292.5% | – | +78.6% | -99.3% | +687.8% | -173.3% | – | +4,542.8% | -22.2% | -193.4% | – | -2,576.1% | – | -26.6% | +5.1% | -96.2% | -14,375.7% | -53.2% | +2,198.3% | -89.4% | – | -143.7% | -48.6% | +29.4% | |
| – | – | -150.0% | – | -144.8% | – | -158.5% | – | +246.1% | -22.5% | -172.4% | – | – | +941.7% | -42.4% | -229.5% | – | – | – | -45.8% | -103.7% | – | – | +364.6% | -98.0% | -4,490.3% | – | – | – | -52.8% | |
| – | -287.2% | – | -3,134.4% | – | – | +12.9% | -7.7% | +6.8% | +15.4% | -9.7% | +97.6% | -20.4% | +142.5% | -46.4% | +19.5% | -23.6% | -49.3% | +121.5% | -46.8% | +2.3% | -114.8% | – | +130.9% | +32.6% | +12.4% | -85.0% | +171.8% | +22.0% | +40.7% |
Data as of: October 1, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.